Supriya Lifescience Financial Results
- Market cap
- ₹7,182 crore
- P/E
- 36.2
- P/B
- 6.00
- ROE
- 19.1%
- Dividend yield
- 0.11%
For the year ended Mar 2022, Supriya Lifescience reported revenue of ₹530 crore and net profit of ₹152 crore, against ₹451 crore and ₹90 crore a year earlier.
Supriya Lifescience annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 530 | 451 | 557 | 680 | 802 | 873 |
| Expenses | 316 | 324 | 384 | 423 | 519 | 583 |
| Operating profit | 214 | 127 | 174 | 256 | 283 | 290 |
| Operating margin % | 40% | 28% | 31% | 38% | 35% | 33% |
| Other income | 8 | 10 | 12 | 13 | 22 | 11 |
| Interest | 4 | 2 | 4 | 0 | 1 | 2 |
| Depreciation | 10 | 12 | 16 | 20 | 28 | 31 |
| Profit before tax | 207 | 123 | 166 | 248 | 275 | 268 |
| Tax % | 27% | 27% | 28% | 24% | 24% | 26% |
| Net profit | 152 | 90 | 119 | 188 | 209 | 198 |
| EPS (₹) | 18.86 | 11.16 | 14.80 | 23.35 | 25.98 | 24.65 |
| Dividend payout % | — | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Supriya Lifescience financial results — frequently asked questions
What is Supriya Lifescience's annual revenue and net profit?
For the financial year ended Mar 2022, Supriya Lifescience's revenue was ₹530 crore and net profit ₹152 crore; net profit rose 68.89% from ₹90 crore in Mar 2023.
How fast has Supriya Lifescience grown over three years?
From Mar 2025 to Mar 2022, Supriya Lifescience's revenue grew at a compound annual rate of -8.0% and net profit at -6.8%. Past growth does not indicate future results.
What is the EPS of Supriya Lifescience?
Annual EPS for Mar 2022 was ₹18.86.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Supriya Lifescience With ATS
Track SUPRIYA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.